Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We seek a strategic and hands-on Senior Director, Regulatory Affairs, Canada who will play a critical role in leading and executing the regional regulatory strategy for our portfolio in Canada. The Senior Director will serve as a strategic partner to Global Regulatory Teams, ensuring alignment of the Canada regulatory strategy with the global and regional company’s objectives. In addition, independently represent regulatory affairs in global and regional cross-functional teams and provide targeted, strategic expertise of one or more therapeutic areas for oncology programs across the Global and JPAC organizations. The candidate must have a thorough understanding of oncology drug development, applicable Canada regulations and is responsible for driving proactive engagement with health authorities including the Health Canada ensuring successful regulatory outcomes. The role will report to the Vice President, General Manager, Canada and dotted line to the SVP, Head of Regulatory Affairs
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior